Multiple end-point analysis reveals cisplatin damage tolerance to be a chemoresistance mechanism in a NSCLC model: implications for predictive testing.

Source:http://linkedlifedata.com/resource/pubmed/id/18074354

Int. J. Cancer 2008 Apr 15 122 8 1810-9

Download in:

View as

General Info

PMID
18074354